Journal article icon

Journal article

Autoantibody-mediated diseases of the CNS: Structure, dysfunction and therapy

Abstract:

The field of neuronal autoantibody associated diseases of the central nervous system has expanded dramatically in the last few years. The range of identified neuronal and glial antibody targets has led to the accurate classification of a number of syndromes which each associate with characteristic clinical features. These diseases are especially important due to their frequent response to immunotherapies. Antibodies against the N-methyl, D-aspartate receptor (NMDAR) and leucine-rich glioma in...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Author
More by this author
Institution:
University of Oxford
Oxford college:
St Hilda's College
Role:
Author
More from this funder
Name:
Fulbright UK-US commission
Funding agency for:
Irani, S
Grant:
P1201
More from this funder
Name:
Epilepsy Research UK
Funding agency for:
Irani, S
Grant:
P1201
More from this funder
Name:
UCB-Oxford University alliance
Funding agency for:
Irani, S
Grant:
P1201
More from this funder
Name:
Wellcome Trust
Funding agency for:
Irani, S
Grant:
P1201
More from this funder
Name:
British Medical Association
Funding agency for:
Irani, S
Grant:
P1201
Publisher:
Elsevier
Journal:
Neuropharmacology More from this journal
Volume:
132
Pages:
71-82
Publication date:
2017-05-01
Acceptance date:
2017-04-29
DOI:
EISSN:
1873-7064
ISSN:
0028-3908
Keywords:
Pubs id:
pubs:692167
UUID:
uuid:e73db6fe-62aa-49f3-82ed-b3bfbee71ea5
Local pid:
pubs:692167
Source identifiers:
692167
Deposit date:
2017-05-03

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP